Information Provided By: 
Fly News Breaks for May 5, 2017
ZTS
May 5, 2017 | 08:09 EDT
Morgan Stanley analyst David Risinger raised Zoetis estimates following the Q1 beat and raised its price target to $61 from $56 saying he is constructive on the company's growth prospects but said valuation is a premium and maintained an Equal Weight rating.
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
